nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A2—Nicotine—ulcerative colitis	0.135	0.535	CbGbCtD
Pramipexole—SLC22A1—Nicotine—ulcerative colitis	0.117	0.465	CbGbCtD
Pramipexole—Hypertension—Methylprednisolone—ulcerative colitis	0.000135	0.000253	CcSEcCtD
Pramipexole—Infection—Hydrocortisone—ulcerative colitis	0.000135	0.000253	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000134	0.000252	CcSEcCtD
Pramipexole—Shock—Hydrocortisone—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Myalgia—Triamcinolone—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Vomiting—Azathioprine—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Myalgia—Methylprednisolone—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Arthralgia—Methylprednisolone—ulcerative colitis	0.000133	0.00025	CcSEcCtD
Pramipexole—Eye disorder—Prednisone—ulcerative colitis	0.000133	0.000249	CcSEcCtD
Pramipexole—Anxiety—Methylprednisolone—ulcerative colitis	0.000132	0.000249	CcSEcCtD
Pramipexole—Tachycardia—Hydrocortisone—ulcerative colitis	0.000132	0.000248	CcSEcCtD
Pramipexole—Rash—Azathioprine—ulcerative colitis	0.000132	0.000248	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000132	0.000248	CcSEcCtD
Pramipexole—Dermatitis—Azathioprine—ulcerative colitis	0.000132	0.000248	CcSEcCtD
Pramipexole—Flushing—Prednisone—ulcerative colitis	0.000132	0.000247	CcSEcCtD
Pramipexole—Skin disorder—Hydrocortisone—ulcerative colitis	0.000132	0.000247	CcSEcCtD
Pramipexole—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000132	0.000247	CcSEcCtD
Pramipexole—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000132	0.000247	CcSEcCtD
Pramipexole—Discomfort—Triamcinolone—ulcerative colitis	0.000131	0.000247	CcSEcCtD
Pramipexole—Discomfort—Methylprednisolone—ulcerative colitis	0.000131	0.000247	CcSEcCtD
Pramipexole—Headache—Azathioprine—ulcerative colitis	0.000131	0.000246	CcSEcCtD
Pramipexole—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000131	0.000246	CcSEcCtD
Pramipexole—Diarrhoea—Mesalazine—ulcerative colitis	0.00013	0.000245	CcSEcCtD
Pramipexole—Dry mouth—Triamcinolone—ulcerative colitis	0.00013	0.000245	CcSEcCtD
Pramipexole—Anorexia—Hydrocortisone—ulcerative colitis	0.000129	0.000243	CcSEcCtD
Pramipexole—Angiopathy—Prednisone—ulcerative colitis	0.000129	0.000242	CcSEcCtD
Pramipexole—Confusional state—Methylprednisolone—ulcerative colitis	0.000128	0.000241	CcSEcCtD
Pramipexole—Immune system disorder—Prednisone—ulcerative colitis	0.000128	0.000241	CcSEcCtD
Pramipexole—Malaise—Dexamethasone—ulcerative colitis	0.000128	0.00024	CcSEcCtD
Pramipexole—Malaise—Betamethasone—ulcerative colitis	0.000128	0.00024	CcSEcCtD
Pramipexole—Oedema—Triamcinolone—ulcerative colitis	0.000128	0.00024	CcSEcCtD
Pramipexole—Vertigo—Dexamethasone—ulcerative colitis	0.000127	0.000239	CcSEcCtD
Pramipexole—Vertigo—Betamethasone—ulcerative colitis	0.000127	0.000239	CcSEcCtD
Pramipexole—Syncope—Dexamethasone—ulcerative colitis	0.000127	0.000239	CcSEcCtD
Pramipexole—Syncope—Betamethasone—ulcerative colitis	0.000127	0.000239	CcSEcCtD
Pramipexole—Infection—Triamcinolone—ulcerative colitis	0.000127	0.000238	CcSEcCtD
Pramipexole—Hypotension—Hydrocortisone—ulcerative colitis	0.000127	0.000238	CcSEcCtD
Pramipexole—Infection—Methylprednisolone—ulcerative colitis	0.000126	0.000238	CcSEcCtD
Pramipexole—Dizziness—Mesalazine—ulcerative colitis	0.000126	0.000237	CcSEcCtD
Pramipexole—Shock—Triamcinolone—ulcerative colitis	0.000125	0.000236	CcSEcCtD
Pramipexole—Insomnia—Prednisolone—ulcerative colitis	0.000125	0.000236	CcSEcCtD
Pramipexole—Alopecia—Prednisone—ulcerative colitis	0.000125	0.000236	CcSEcCtD
Pramipexole—Shock—Methylprednisolone—ulcerative colitis	0.000125	0.000235	CcSEcCtD
Pramipexole—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000125	0.000235	CcSEcCtD
Pramipexole—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000125	0.000234	CcSEcCtD
Pramipexole—Loss of consciousness—Betamethasone—ulcerative colitis	0.000125	0.000234	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—ulcerative colitis	0.000125	0.000234	CcSEcCtD
Pramipexole—Tachycardia—Triamcinolone—ulcerative colitis	0.000124	0.000234	CcSEcCtD
Pramipexole—Mental disorder—Prednisone—ulcerative colitis	0.000124	0.000234	CcSEcCtD
Pramipexole—Nausea—Azathioprine—ulcerative colitis	0.000124	0.000233	CcSEcCtD
Pramipexole—Tachycardia—Methylprednisolone—ulcerative colitis	0.000124	0.000233	CcSEcCtD
Pramipexole—Skin disorder—Methylprednisolone—ulcerative colitis	0.000124	0.000232	CcSEcCtD
Pramipexole—Malnutrition—Prednisone—ulcerative colitis	0.000123	0.000232	CcSEcCtD
Pramipexole—Erythema—Prednisone—ulcerative colitis	0.000123	0.000232	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000123	0.000232	CcSEcCtD
Pramipexole—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000123	0.000232	CcSEcCtD
Pramipexole—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000123	0.000231	CcSEcCtD
Pramipexole—Convulsion—Betamethasone—ulcerative colitis	0.000123	0.000231	CcSEcCtD
Pramipexole—Convulsion—Dexamethasone—ulcerative colitis	0.000123	0.000231	CcSEcCtD
Pramipexole—Insomnia—Hydrocortisone—ulcerative colitis	0.000123	0.00023	CcSEcCtD
Pramipexole—Hypertension—Dexamethasone—ulcerative colitis	0.000122	0.00023	CcSEcCtD
Pramipexole—Hypertension—Betamethasone—ulcerative colitis	0.000122	0.00023	CcSEcCtD
Pramipexole—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000122	0.000229	CcSEcCtD
Pramipexole—Vomiting—Mesalazine—ulcerative colitis	0.000121	0.000228	CcSEcCtD
Pramipexole—Myalgia—Dexamethasone—ulcerative colitis	0.000121	0.000227	CcSEcCtD
Pramipexole—Myalgia—Betamethasone—ulcerative colitis	0.000121	0.000227	CcSEcCtD
Pramipexole—Anxiety—Dexamethasone—ulcerative colitis	0.00012	0.000226	CcSEcCtD
Pramipexole—Anxiety—Betamethasone—ulcerative colitis	0.00012	0.000226	CcSEcCtD
Pramipexole—Rash—Mesalazine—ulcerative colitis	0.00012	0.000226	CcSEcCtD
Pramipexole—Dermatitis—Mesalazine—ulcerative colitis	0.00012	0.000226	CcSEcCtD
Pramipexole—Headache—Mesalazine—ulcerative colitis	0.000119	0.000224	CcSEcCtD
Pramipexole—Discomfort—Dexamethasone—ulcerative colitis	0.000119	0.000224	CcSEcCtD
Pramipexole—Discomfort—Betamethasone—ulcerative colitis	0.000119	0.000224	CcSEcCtD
Pramipexole—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000119	0.000224	CcSEcCtD
Pramipexole—Hypotension—Methylprednisolone—ulcerative colitis	0.000119	0.000224	CcSEcCtD
Pramipexole—Pain—Prednisolone—ulcerative colitis	0.000119	0.000223	CcSEcCtD
Pramipexole—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000118	0.000221	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000117	0.00022	CcSEcCtD
Pramipexole—Fatigue—Hydrocortisone—ulcerative colitis	0.000117	0.00022	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—ulcerative colitis	0.000116	0.000219	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000116	0.000218	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000116	0.000218	CcSEcCtD
Pramipexole—Pain—Hydrocortisone—ulcerative colitis	0.000116	0.000218	CcSEcCtD
Pramipexole—Oedema—Dexamethasone—ulcerative colitis	0.000116	0.000218	CcSEcCtD
Pramipexole—Oedema—Betamethasone—ulcerative colitis	0.000116	0.000218	CcSEcCtD
Pramipexole—Insomnia—Triamcinolone—ulcerative colitis	0.000115	0.000217	CcSEcCtD
Pramipexole—Insomnia—Methylprednisolone—ulcerative colitis	0.000115	0.000216	CcSEcCtD
Pramipexole—Infection—Betamethasone—ulcerative colitis	0.000115	0.000216	CcSEcCtD
Pramipexole—Infection—Dexamethasone—ulcerative colitis	0.000115	0.000216	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—ulcerative colitis	0.000115	0.000215	CcSEcCtD
Pramipexole—Paraesthesia—Triamcinolone—ulcerative colitis	0.000115	0.000215	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—ulcerative colitis	0.000114	0.000215	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000114	0.000215	CcSEcCtD
Pramipexole—Anaemia—Prednisone—ulcerative colitis	0.000114	0.000215	CcSEcCtD
Pramipexole—Shock—Dexamethasone—ulcerative colitis	0.000114	0.000214	CcSEcCtD
Pramipexole—Shock—Betamethasone—ulcerative colitis	0.000114	0.000214	CcSEcCtD
Pramipexole—Dyspnoea—Triamcinolone—ulcerative colitis	0.000114	0.000214	CcSEcCtD
Pramipexole—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Nervous system disorder—Betamethasone—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Agitation—Prednisone—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Nausea—Mesalazine—ulcerative colitis	0.000113	0.000213	CcSEcCtD
Pramipexole—Tachycardia—Betamethasone—ulcerative colitis	0.000113	0.000212	CcSEcCtD
Pramipexole—Tachycardia—Dexamethasone—ulcerative colitis	0.000113	0.000212	CcSEcCtD
Pramipexole—Dyspepsia—Triamcinolone—ulcerative colitis	0.000112	0.000211	CcSEcCtD
Pramipexole—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000112	0.000211	CcSEcCtD
Pramipexole—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000112	0.00021	CcSEcCtD
Pramipexole—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000112	0.00021	CcSEcCtD
Pramipexole—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000112	0.00021	CcSEcCtD
Pramipexole—Malaise—Prednisone—ulcerative colitis	0.000111	0.000209	CcSEcCtD
Pramipexole—Vertigo—Prednisone—ulcerative colitis	0.000111	0.000209	CcSEcCtD
Pramipexole—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000111	0.000208	CcSEcCtD
Pramipexole—Syncope—Prednisone—ulcerative colitis	0.000111	0.000208	CcSEcCtD
Pramipexole—Anorexia—Betamethasone—ulcerative colitis	0.00011	0.000207	CcSEcCtD
Pramipexole—Anorexia—Dexamethasone—ulcerative colitis	0.00011	0.000207	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—ulcerative colitis	0.00011	0.000207	CcSEcCtD
Pramipexole—Fatigue—Triamcinolone—ulcerative colitis	0.00011	0.000207	CcSEcCtD
Pramipexole—Fatigue—Methylprednisolone—ulcerative colitis	0.00011	0.000206	CcSEcCtD
Pramipexole—Pain—Triamcinolone—ulcerative colitis	0.000109	0.000205	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—ulcerative colitis	0.000109	0.000204	CcSEcCtD
Pramipexole—Hypotension—Betamethasone—ulcerative colitis	0.000108	0.000203	CcSEcCtD
Pramipexole—Hypotension—Dexamethasone—ulcerative colitis	0.000108	0.000203	CcSEcCtD
Pramipexole—Urticaria—Hydrocortisone—ulcerative colitis	0.000108	0.000202	CcSEcCtD
Pramipexole—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000107	0.000201	CcSEcCtD
Pramipexole—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000107	0.000201	CcSEcCtD
Pramipexole—Convulsion—Prednisone—ulcerative colitis	0.000107	0.000201	CcSEcCtD
Pramipexole—Hypertension—Prednisone—ulcerative colitis	0.000107	0.0002	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000105	0.000198	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000105	0.000198	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—ulcerative colitis	0.000105	0.000198	CcSEcCtD
Pramipexole—Myalgia—Prednisone—ulcerative colitis	0.000105	0.000198	CcSEcCtD
Pramipexole—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000105	0.000198	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000105	0.000197	CcSEcCtD
Pramipexole—Anxiety—Prednisone—ulcerative colitis	0.000105	0.000197	CcSEcCtD
Pramipexole—Insomnia—Betamethasone—ulcerative colitis	0.000105	0.000197	CcSEcCtD
Pramipexole—Insomnia—Dexamethasone—ulcerative colitis	0.000105	0.000197	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000104	0.000196	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000104	0.000196	CcSEcCtD
Pramipexole—Paraesthesia—Betamethasone—ulcerative colitis	0.000104	0.000195	CcSEcCtD
Pramipexole—Paraesthesia—Dexamethasone—ulcerative colitis	0.000104	0.000195	CcSEcCtD
Pramipexole—Discomfort—Prednisone—ulcerative colitis	0.000104	0.000195	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—ulcerative colitis	0.000102	0.000192	CcSEcCtD
Pramipexole—Dyspepsia—Betamethasone—ulcerative colitis	0.000102	0.000191	CcSEcCtD
Pramipexole—Dyspepsia—Dexamethasone—ulcerative colitis	0.000102	0.000191	CcSEcCtD
Pramipexole—Urticaria—Triamcinolone—ulcerative colitis	0.000101	0.00019	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—ulcerative colitis	0.000101	0.00019	CcSEcCtD
Pramipexole—Body temperature increased—Triamcinolone—ulcerative colitis	0.000101	0.00019	CcSEcCtD
Pramipexole—Oedema—Prednisone—ulcerative colitis	0.000101	0.000189	CcSEcCtD
Pramipexole—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000101	0.000189	CcSEcCtD
Pramipexole—Decreased appetite—Dexamethasone—ulcerative colitis	0.000101	0.000189	CcSEcCtD
Pramipexole—Decreased appetite—Betamethasone—ulcerative colitis	0.000101	0.000189	CcSEcCtD
Pramipexole—Infection—Prednisone—ulcerative colitis	0.0001	0.000188	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.99e-05	0.000188	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.99e-05	0.000188	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.98e-05	0.000188	CcSEcCtD
Pramipexole—Fatigue—Betamethasone—ulcerative colitis	9.98e-05	0.000188	CcSEcCtD
Pramipexole—Fatigue—Dexamethasone—ulcerative colitis	9.98e-05	0.000188	CcSEcCtD
Pramipexole—Shock—Prednisone—ulcerative colitis	9.92e-05	0.000186	CcSEcCtD
Pramipexole—Pain—Dexamethasone—ulcerative colitis	9.9e-05	0.000186	CcSEcCtD
Pramipexole—Pain—Betamethasone—ulcerative colitis	9.9e-05	0.000186	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—ulcerative colitis	9.88e-05	0.000186	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—ulcerative colitis	9.84e-05	0.000185	CcSEcCtD
Pramipexole—Skin disorder—Prednisone—ulcerative colitis	9.79e-05	0.000184	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—ulcerative colitis	9.74e-05	0.000183	CcSEcCtD
Pramipexole—Asthenia—Hydrocortisone—ulcerative colitis	9.72e-05	0.000183	CcSEcCtD
Pramipexole—Anorexia—Prednisone—ulcerative colitis	9.61e-05	0.000181	CcSEcCtD
Pramipexole—Pruritus—Hydrocortisone—ulcerative colitis	9.58e-05	0.00018	CcSEcCtD
Pramipexole—Feeling abnormal—Dexamethasone—ulcerative colitis	9.54e-05	0.000179	CcSEcCtD
Pramipexole—Feeling abnormal—Betamethasone—ulcerative colitis	9.54e-05	0.000179	CcSEcCtD
Pramipexole—HTR2A—enteric nervous system—ulcerative colitis	9.49e-05	0.362	CbGeAlD
Pramipexole—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.46e-05	0.000178	CcSEcCtD
Pramipexole—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.46e-05	0.000178	CcSEcCtD
Pramipexole—Hypersensitivity—Triamcinolone—ulcerative colitis	9.4e-05	0.000177	CcSEcCtD
Pramipexole—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.38e-05	0.000176	CcSEcCtD
Pramipexole—Diarrhoea—Hydrocortisone—ulcerative colitis	9.27e-05	0.000174	CcSEcCtD
Pramipexole—Urticaria—Betamethasone—ulcerative colitis	9.19e-05	0.000173	CcSEcCtD
Pramipexole—Urticaria—Dexamethasone—ulcerative colitis	9.19e-05	0.000173	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.18e-05	0.000173	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—ulcerative colitis	9.17e-05	0.000172	CcSEcCtD
Pramipexole—Asthenia—Triamcinolone—ulcerative colitis	9.15e-05	0.000172	CcSEcCtD
Pramipexole—Body temperature increased—Dexamethasone—ulcerative colitis	9.15e-05	0.000172	CcSEcCtD
Pramipexole—Abdominal pain—Betamethasone—ulcerative colitis	9.15e-05	0.000172	CcSEcCtD
Pramipexole—Body temperature increased—Betamethasone—ulcerative colitis	9.15e-05	0.000172	CcSEcCtD
Pramipexole—Abdominal pain—Dexamethasone—ulcerative colitis	9.15e-05	0.000172	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—ulcerative colitis	9.13e-05	0.000172	CcSEcCtD
Pramipexole—Insomnia—Prednisone—ulcerative colitis	9.12e-05	0.000171	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—ulcerative colitis	9.05e-05	0.00017	CcSEcCtD
Pramipexole—Pruritus—Triamcinolone—ulcerative colitis	9.02e-05	0.00017	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—ulcerative colitis	9e-05	0.000169	CcSEcCtD
Pramipexole—Dizziness—Hydrocortisone—ulcerative colitis	8.96e-05	0.000168	CcSEcCtD
Pramipexole—Dyspepsia—Prednisone—ulcerative colitis	8.87e-05	0.000167	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—ulcerative colitis	8.76e-05	0.000165	CcSEcCtD
Pramipexole—Rash—Prednisolone—ulcerative colitis	8.74e-05	0.000164	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—ulcerative colitis	8.74e-05	0.000164	CcSEcCtD
Pramipexole—Diarrhoea—Methylprednisolone—ulcerative colitis	8.71e-05	0.000164	CcSEcCtD
Pramipexole—Fatigue—Prednisone—ulcerative colitis	8.69e-05	0.000163	CcSEcCtD
Pramipexole—Headache—Prednisolone—ulcerative colitis	8.69e-05	0.000163	CcSEcCtD
Pramipexole—Constipation—Prednisone—ulcerative colitis	8.62e-05	0.000162	CcSEcCtD
Pramipexole—Vomiting—Hydrocortisone—ulcerative colitis	8.61e-05	0.000162	CcSEcCtD
Pramipexole—Rash—Hydrocortisone—ulcerative colitis	8.54e-05	0.000161	CcSEcCtD
Pramipexole—Dermatitis—Hydrocortisone—ulcerative colitis	8.53e-05	0.00016	CcSEcCtD
Pramipexole—Headache—Hydrocortisone—ulcerative colitis	8.49e-05	0.00016	CcSEcCtD
Pramipexole—Dizziness—Triamcinolone—ulcerative colitis	8.43e-05	0.000159	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—ulcerative colitis	8.42e-05	0.000158	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisone—ulcerative colitis	8.3e-05	0.000156	CcSEcCtD
Pramipexole—Asthenia—Dexamethasone—ulcerative colitis	8.3e-05	0.000156	CcSEcCtD
Pramipexole—Asthenia—Betamethasone—ulcerative colitis	8.3e-05	0.000156	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—ulcerative colitis	8.24e-05	0.000155	CcSEcCtD
Pramipexole—Nausea—Prednisolone—ulcerative colitis	8.24e-05	0.000155	CcSEcCtD
Pramipexole—Pruritus—Betamethasone—ulcerative colitis	8.19e-05	0.000154	CcSEcCtD
Pramipexole—Pruritus—Dexamethasone—ulcerative colitis	8.19e-05	0.000154	CcSEcCtD
Pramipexole—Vomiting—Triamcinolone—ulcerative colitis	8.11e-05	0.000152	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—ulcerative colitis	8.09e-05	0.000152	CcSEcCtD
Pramipexole—Nausea—Hydrocortisone—ulcerative colitis	8.05e-05	0.000151	CcSEcCtD
Pramipexole—Rash—Triamcinolone—ulcerative colitis	8.04e-05	0.000151	CcSEcCtD
Pramipexole—Dermatitis—Triamcinolone—ulcerative colitis	8.03e-05	0.000151	CcSEcCtD
Pramipexole—Rash—Methylprednisolone—ulcerative colitis	8.02e-05	0.000151	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—ulcerative colitis	8.02e-05	0.000151	CcSEcCtD
Pramipexole—Urticaria—Prednisone—ulcerative colitis	8.01e-05	0.00015	CcSEcCtD
Pramipexole—Headache—Triamcinolone—ulcerative colitis	7.99e-05	0.00015	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—ulcerative colitis	7.97e-05	0.00015	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—ulcerative colitis	7.97e-05	0.00015	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—ulcerative colitis	7.97e-05	0.00015	CcSEcCtD
Pramipexole—Diarrhoea—Dexamethasone—ulcerative colitis	7.92e-05	0.000149	CcSEcCtD
Pramipexole—Diarrhoea—Betamethasone—ulcerative colitis	7.92e-05	0.000149	CcSEcCtD
Pramipexole—Dizziness—Dexamethasone—ulcerative colitis	7.65e-05	0.000144	CcSEcCtD
Pramipexole—Dizziness—Betamethasone—ulcerative colitis	7.65e-05	0.000144	CcSEcCtD
Pramipexole—Nausea—Triamcinolone—ulcerative colitis	7.58e-05	0.000142	CcSEcCtD
Pramipexole—Nausea—Methylprednisolone—ulcerative colitis	7.56e-05	0.000142	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisone—ulcerative colitis	7.43e-05	0.00014	CcSEcCtD
Pramipexole—Vomiting—Betamethasone—ulcerative colitis	7.36e-05	0.000138	CcSEcCtD
Pramipexole—Vomiting—Dexamethasone—ulcerative colitis	7.36e-05	0.000138	CcSEcCtD
Pramipexole—Rash—Dexamethasone—ulcerative colitis	7.3e-05	0.000137	CcSEcCtD
Pramipexole—Rash—Betamethasone—ulcerative colitis	7.3e-05	0.000137	CcSEcCtD
Pramipexole—Dermatitis—Betamethasone—ulcerative colitis	7.29e-05	0.000137	CcSEcCtD
Pramipexole—Dermatitis—Dexamethasone—ulcerative colitis	7.29e-05	0.000137	CcSEcCtD
Pramipexole—Headache—Dexamethasone—ulcerative colitis	7.25e-05	0.000136	CcSEcCtD
Pramipexole—Headache—Betamethasone—ulcerative colitis	7.25e-05	0.000136	CcSEcCtD
Pramipexole—Asthenia—Prednisone—ulcerative colitis	7.23e-05	0.000136	CcSEcCtD
Pramipexole—HTR2A—myenteric nerve plexus—ulcerative colitis	7.19e-05	0.275	CbGeAlD
Pramipexole—Pruritus—Prednisone—ulcerative colitis	7.13e-05	0.000134	CcSEcCtD
Pramipexole—Diarrhoea—Prednisone—ulcerative colitis	6.9e-05	0.00013	CcSEcCtD
Pramipexole—Nausea—Dexamethasone—ulcerative colitis	6.87e-05	0.000129	CcSEcCtD
Pramipexole—Nausea—Betamethasone—ulcerative colitis	6.87e-05	0.000129	CcSEcCtD
Pramipexole—Dizziness—Prednisone—ulcerative colitis	6.66e-05	0.000125	CcSEcCtD
Pramipexole—Vomiting—Prednisone—ulcerative colitis	6.41e-05	0.00012	CcSEcCtD
Pramipexole—Rash—Prednisone—ulcerative colitis	6.35e-05	0.000119	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—ulcerative colitis	6.35e-05	0.000119	CcSEcCtD
Pramipexole—Headache—Prednisone—ulcerative colitis	6.31e-05	0.000119	CcSEcCtD
Pramipexole—Nausea—Prednisone—ulcerative colitis	5.99e-05	0.000113	CcSEcCtD
Pramipexole—DRD2—Signaling Pathways—CALM3—ulcerative colitis	2.8e-05	0.00013	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL2—ulcerative colitis	2.79e-05	0.000129	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—JAK2—ulcerative colitis	2.78e-05	0.000129	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RIPK2—ulcerative colitis	2.75e-05	0.000128	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CALM3—ulcerative colitis	2.75e-05	0.000128	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ADCY5—ulcerative colitis	2.75e-05	0.000127	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL2—ulcerative colitis	2.75e-05	0.000127	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ABCB1—ulcerative colitis	2.75e-05	0.000127	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CXCL8—ulcerative colitis	2.74e-05	0.000127	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—IL2—ulcerative colitis	2.72e-05	0.000126	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADRB2—ulcerative colitis	2.72e-05	0.000126	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RIPK2—ulcerative colitis	2.71e-05	0.000126	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADRB2—ulcerative colitis	2.71e-05	0.000126	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—IL2—ulcerative colitis	2.69e-05	0.000125	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ADCY5—ulcerative colitis	2.69e-05	0.000125	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—JAK2—ulcerative colitis	2.69e-05	0.000124	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ADCY5—ulcerative colitis	2.67e-05	0.000124	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—JAK2—ulcerative colitis	2.67e-05	0.000124	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ADCY5—ulcerative colitis	2.65e-05	0.000123	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADRB2—ulcerative colitis	2.63e-05	0.000122	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL2—ulcerative colitis	2.62e-05	0.000122	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—JAK2—ulcerative colitis	2.6e-05	0.00012	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—CXCL8—ulcerative colitis	2.59e-05	0.00012	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	2.58e-05	0.00012	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ADCY5—ulcerative colitis	2.56e-05	0.000119	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—CXCL8—ulcerative colitis	2.55e-05	0.000118	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—CXCL8—ulcerative colitis	2.54e-05	0.000118	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—JAK2—ulcerative colitis	2.53e-05	0.000117	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—JAK2—ulcerative colitis	2.52e-05	0.000117	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	2.5e-05	0.000116	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL2—ulcerative colitis	2.47e-05	0.000115	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	2.47e-05	0.000114	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—ulcerative colitis	2.47e-05	0.000114	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—CXCL8—ulcerative colitis	2.45e-05	0.000114	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RELA—ulcerative colitis	2.44e-05	0.000113	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL2—ulcerative colitis	2.44e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—JAK2—ulcerative colitis	2.44e-05	0.000113	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—CXCL8—ulcerative colitis	2.44e-05	0.000113	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—IL2—ulcerative colitis	2.43e-05	0.000112	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—JAK2—ulcerative colitis	2.43e-05	0.000112	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ADCY5—ulcerative colitis	2.39e-05	0.000111	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADRB2—ulcerative colitis	2.39e-05	0.000111	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—CXCL8—ulcerative colitis	2.37e-05	0.00011	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—JAK2—ulcerative colitis	2.36e-05	0.000109	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—JAK2—ulcerative colitis	2.36e-05	0.000109	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADRB2—ulcerative colitis	2.35e-05	0.000109	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—IL2—ulcerative colitis	2.34e-05	0.000109	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—IL2—ulcerative colitis	2.33e-05	0.000108	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ABCB1—ulcerative colitis	2.33e-05	0.000108	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—JAK2—ulcerative colitis	2.32e-05	0.000108	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ADCY5—ulcerative colitis	2.31e-05	0.000107	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CXCL8—ulcerative colitis	2.31e-05	0.000107	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—ulcerative colitis	2.3e-05	0.000107	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CXCL8—ulcerative colitis	2.3e-05	0.000107	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ADCY5—ulcerative colitis	2.3e-05	0.000107	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	2.27e-05	0.000105	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—IL2—ulcerative colitis	2.27e-05	0.000105	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ADCY5—ulcerative colitis	2.24e-05	0.000104	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CXCL8—ulcerative colitis	2.23e-05	0.000103	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CXCL8—ulcerative colitis	2.21e-05	0.000103	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL2—ulcerative colitis	2.2e-05	0.000102	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL2—ulcerative colitis	2.2e-05	0.000102	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—ulcerative colitis	2.19e-05	0.000101	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ADCY5—ulcerative colitis	2.17e-05	0.000101	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—CXCL8—ulcerative colitis	2.15e-05	9.98e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CXCL8—ulcerative colitis	2.15e-05	9.98e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—JAK2—ulcerative colitis	2.14e-05	9.93e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	2.14e-05	9.92e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL2—ulcerative colitis	2.13e-05	9.86e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CXCL8—ulcerative colitis	2.12e-05	9.82e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL2—ulcerative colitis	2.12e-05	9.81e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	2.11e-05	9.78e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—JAK2—ulcerative colitis	2.11e-05	9.77e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MMP9—ulcerative colitis	2.08e-05	9.65e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NFKB1—ulcerative colitis	2.06e-05	9.55e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL2—ulcerative colitis	2.06e-05	9.54e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL2—ulcerative colitis	2.06e-05	9.53e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PPARG—ulcerative colitis	2.05e-05	9.51e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ADCY5—ulcerative colitis	2.03e-05	9.41e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—IL2—ulcerative colitis	2.02e-05	9.38e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ADCY5—ulcerative colitis	2e-05	9.25e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PPARG—ulcerative colitis	1.99e-05	9.25e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CXCL8—ulcerative colitis	1.95e-05	9.06e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—JAK2—ulcerative colitis	1.93e-05	8.95e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.93e-05	8.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.92e-05	8.91e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	1.92e-05	8.89e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PPARG—ulcerative colitis	1.91e-05	8.86e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—JAK2—ulcerative colitis	1.89e-05	8.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—ulcerative colitis	1.87e-05	8.67e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RELA—ulcerative colitis	1.87e-05	8.67e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL2—ulcerative colitis	1.87e-05	8.66e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—JAK2—ulcerative colitis	1.86e-05	8.63e-05	CbGpPWpGaD
Pramipexole—DRD5—lymphoid tissue—ulcerative colitis	1.85e-05	0.0707	CbGeAlD
Pramipexole—DRD5—Signaling Pathways—STAT3—ulcerative colitis	1.85e-05	8.58e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—ulcerative colitis	1.84e-05	8.55e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	1.84e-05	8.53e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL2—ulcerative colitis	1.84e-05	8.52e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RELA—ulcerative colitis	1.83e-05	8.49e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	1.82e-05	8.42e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RELA—ulcerative colitis	1.8e-05	8.35e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—ulcerative colitis	1.79e-05	8.31e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—JAK2—ulcerative colitis	1.78e-05	8.24e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CXCL8—ulcerative colitis	1.76e-05	8.17e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	1.75e-05	8.11e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CXCL8—ulcerative colitis	1.73e-05	8e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RELA—ulcerative colitis	1.72e-05	7.98e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—ulcerative colitis	1.72e-05	7.97e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—ulcerative colitis	1.72e-05	7.95e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CXCL8—ulcerative colitis	1.7e-05	7.87e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL2—ulcerative colitis	1.68e-05	7.81e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—ulcerative colitis	1.68e-05	7.77e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—JAK2—ulcerative colitis	1.68e-05	7.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	1.67e-05	7.75e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—JAK2—ulcerative colitis	1.65e-05	7.66e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL2—ulcerative colitis	1.65e-05	7.65e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—ulcerative colitis	1.64e-05	7.61e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL2—ulcerative colitis	1.62e-05	7.52e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RELA—ulcerative colitis	1.62e-05	7.52e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CXCL8—ulcerative colitis	1.62e-05	7.52e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PPARG—ulcerative colitis	1.62e-05	7.51e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—ulcerative colitis	1.61e-05	7.49e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—ulcerative colitis	1.61e-05	7.48e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RELA—ulcerative colitis	1.6e-05	7.42e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—ulcerative colitis	1.59e-05	7.39e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NFKB1—ulcerative colitis	1.58e-05	7.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—ulcerative colitis	1.57e-05	7.27e-05	CbGpPWpGaD
Pramipexole—SLC22A2—digestive system—ulcerative colitis	1.57e-05	0.0598	CbGeAlD
Pramipexole—HTR1B—Signaling Pathways—MMP9—ulcerative colitis	1.56e-05	7.24e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL2—ulcerative colitis	1.55e-05	7.18e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NFKB1—ulcerative colitis	1.54e-05	7.16e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—ulcerative colitis	1.54e-05	7.15e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—ulcerative colitis	1.54e-05	7.12e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	1.53e-05	7.09e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NFKB1—ulcerative colitis	1.52e-05	7.05e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CXCL8—ulcerative colitis	1.51e-05	6.99e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—ulcerative colitis	1.5e-05	6.97e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—JAK2—ulcerative colitis	1.49e-05	6.92e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—ulcerative colitis	1.47e-05	6.8e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2—ulcerative colitis	1.46e-05	6.77e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—ulcerative colitis	1.46e-05	6.75e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—ulcerative colitis	1.45e-05	6.74e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NFKB1—ulcerative colitis	1.45e-05	6.73e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RELA—ulcerative colitis	1.45e-05	6.7e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2—ulcerative colitis	1.44e-05	6.68e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—JAK2—ulcerative colitis	1.44e-05	6.68e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—ulcerative colitis	1.43e-05	6.65e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—JAK2—ulcerative colitis	1.43e-05	6.64e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—STAT3—ulcerative colitis	1.42e-05	6.57e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—ulcerative colitis	1.41e-05	6.55e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RELA—ulcerative colitis	1.4e-05	6.47e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—JAK2—ulcerative colitis	1.39e-05	6.46e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RELA—ulcerative colitis	1.39e-05	6.43e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—STAT3—ulcerative colitis	1.39e-05	6.43e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—ulcerative colitis	1.38e-05	6.41e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	1.37e-05	6.34e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—STAT3—ulcerative colitis	1.37e-05	6.33e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—ulcerative colitis	1.36e-05	6.33e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CXCL8—ulcerative colitis	1.36e-05	6.31e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RELA—ulcerative colitis	1.35e-05	6.26e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NFKB1—ulcerative colitis	1.35e-05	6.26e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CXCL8—ulcerative colitis	1.31e-05	6.1e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—ulcerative colitis	1.31e-05	6.09e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CXCL8—ulcerative colitis	1.31e-05	6.06e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—STAT3—ulcerative colitis	1.3e-05	6.04e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2—ulcerative colitis	1.3e-05	6.03e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—ulcerative colitis	1.3e-05	6e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—ulcerative colitis	1.29e-05	5.99e-05	CbGpPWpGaD
Pramipexole—HTR2B—smooth muscle tissue—ulcerative colitis	1.29e-05	0.0493	CbGeAlD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—ulcerative colitis	1.29e-05	5.96e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—ulcerative colitis	1.27e-05	5.91e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CXCL8—ulcerative colitis	1.27e-05	5.9e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—ulcerative colitis	1.27e-05	5.87e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—JAK2—ulcerative colitis	1.26e-05	5.86e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2—ulcerative colitis	1.26e-05	5.82e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—ulcerative colitis	1.25e-05	5.8e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2—ulcerative colitis	1.25e-05	5.79e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—JAK2—ulcerative colitis	1.24e-05	5.77e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—ulcerative colitis	1.24e-05	5.77e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—ulcerative colitis	1.23e-05	5.71e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—STAT3—ulcerative colitis	1.23e-05	5.7e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RELA—ulcerative colitis	1.22e-05	5.68e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NFKB1—ulcerative colitis	1.22e-05	5.65e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2—ulcerative colitis	1.22e-05	5.64e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—STAT3—ulcerative colitis	1.21e-05	5.62e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—ulcerative colitis	1.21e-05	5.61e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—ulcerative colitis	1.21e-05	5.6e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RELA—ulcerative colitis	1.21e-05	5.59e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—ulcerative colitis	1.19e-05	5.51e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—ulcerative colitis	1.18e-05	5.48e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NFKB1—ulcerative colitis	1.18e-05	5.45e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NFKB1—ulcerative colitis	1.17e-05	5.43e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL8—ulcerative colitis	1.15e-05	5.35e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—ulcerative colitis	1.15e-05	5.33e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	1.14e-05	5.28e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NFKB1—ulcerative colitis	1.14e-05	5.28e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL8—ulcerative colitis	1.14e-05	5.27e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	1.13e-05	5.25e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—ulcerative colitis	1.12e-05	5.21e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2—ulcerative colitis	1.1e-05	5.11e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—ulcerative colitis	1.1e-05	5.09e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	1.1e-05	5.08e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—STAT3—ulcerative colitis	1.1e-05	5.08e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2—ulcerative colitis	1.09e-05	5.03e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—ulcerative colitis	1.08e-05	5.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—ulcerative colitis	1.08e-05	5.01e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—ulcerative colitis	1.06e-05	4.91e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—STAT3—ulcerative colitis	1.06e-05	4.9e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—STAT3—ulcerative colitis	1.05e-05	4.88e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—ulcerative colitis	1.04e-05	4.84e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—ulcerative colitis	1.04e-05	4.83e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	1.03e-05	4.79e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NFKB1—ulcerative colitis	1.03e-05	4.79e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—ulcerative colitis	1.03e-05	4.76e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—STAT3—ulcerative colitis	1.02e-05	4.74e-05	CbGpPWpGaD
Pramipexole—HTR2B—digestive system—ulcerative colitis	1.02e-05	0.0389	CbGeAlD
Pramipexole—HTR2A—Signaling Pathways—NFKB1—ulcerative colitis	1.02e-05	4.71e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—ulcerative colitis	1.02e-05	4.71e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—ulcerative colitis	9.95e-06	4.61e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—ulcerative colitis	9.9e-06	4.59e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	9.88e-06	4.58e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	9.83e-06	4.56e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—ulcerative colitis	9.8e-06	4.54e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—ulcerative colitis	9.75e-06	4.52e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—ulcerative colitis	9.69e-06	4.49e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—ulcerative colitis	9.54e-06	4.42e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—ulcerative colitis	9.48e-06	4.4e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—ulcerative colitis	9.38e-06	4.35e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	9.35e-06	4.33e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—STAT3—ulcerative colitis	9.28e-06	4.3e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—ulcerative colitis	9.26e-06	4.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	9.25e-06	4.29e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—STAT3—ulcerative colitis	9.13e-06	4.23e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—ulcerative colitis	9.11e-06	4.22e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—ulcerative colitis	8.61e-06	3.99e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—ulcerative colitis	8.59e-06	3.98e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—ulcerative colitis	8.47e-06	3.93e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—ulcerative colitis	8.47e-06	3.93e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—ulcerative colitis	8.36e-06	3.87e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	8.31e-06	3.85e-05	CbGpPWpGaD
Pramipexole—SLC22A1—liver—ulcerative colitis	8.24e-06	0.0315	CbGeAlD
Pramipexole—HTR1A—Signaling Pathways—TP53—ulcerative colitis	8.07e-06	3.74e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—ulcerative colitis	8.03e-06	3.72e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—ulcerative colitis	7.81e-06	3.62e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	7.7e-06	3.57e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—ulcerative colitis	7.65e-06	3.55e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—ulcerative colitis	7.39e-06	3.42e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—ulcerative colitis	7.35e-06	3.41e-05	CbGpPWpGaD
Pramipexole—HTR2A—epithelium—ulcerative colitis	7.16e-06	0.0273	CbGeAlD
Pramipexole—ADRA2C—Signaling Pathways—IL6—ulcerative colitis	7.15e-06	3.31e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—ulcerative colitis	7.08e-06	3.28e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—ulcerative colitis	6.97e-06	3.23e-05	CbGpPWpGaD
Pramipexole—HTR2A—smooth muscle tissue—ulcerative colitis	6.9e-06	0.0263	CbGeAlD
Pramipexole—DRD2—Signaling Pathways—IL6—ulcerative colitis	6.48e-06	3.01e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—ulcerative colitis	6.38e-06	2.96e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	6.34e-06	2.94e-05	CbGpPWpGaD
Pramipexole—ADRA2C—liver—ulcerative colitis	5.98e-06	0.0228	CbGeAlD
Pramipexole—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	5.8e-06	2.69e-05	CbGpPWpGaD
Pramipexole—HTR2A—digestive system—ulcerative colitis	5.45e-06	0.0208	CbGeAlD
Pramipexole—HTR2A—liver—ulcerative colitis	4.06e-06	0.0155	CbGeAlD
